2023 | Comparison of initial and sequential salvage brain-directed treatment in patients with 1–4 vs. 5–10 brain metastases from breast cancer (KROG 16–12) | 김규보; 정원근 | Article |
2022 | Treatment Outcomes according to the EndoPredict Score in ER-Positive, HER2-Negative Early Breast Cancer | 문병인; 김규보; 정원근 | Article |
2020 | Metabolic changes in breast cancer on dual-time-point 18F-FDG PET/CT imaging according to primary tumor uptake and background parenchymal enhancement | 김범산; 윤혜전; 김혜옥; 강서영 | Article |
2021 | New brain metastases after whole-brain radiotherapy of initial brain metastases in breast cancer patients: the significance of molecular subtypes (KROG 16-12) | 김규보; 김경수 | Article |
2021 | Feasibility and safety of breast-conserving surgery via a periareolar incision for cancers located far from the nipple-areolar complex: a retrospective study | 임우성; 이지혜; 우주현; 백세현 | Article |
2016 | Age-related reduction of antibody response against the human endogenous retrovirus K envelope in women | 김승철; 문병인; 이준우 | Article |
2023 | Estrogen Effects Differ Between Medium Maintenance and Replacement from Transcriptional and Clinical Perspectives in T47D Breast Cancer Cells | 임우성; 백세현; 김종규 | Article |
2021 | Response to neoadjuvant chemotherapy based on pathologic complete response in very young patients with ER-positive breast cancer: a large, multicenter, observational study | 임우성; 우주현 | Article |
2020 | Survival outcomes of breast cancer patients with brain metastases: A multicenter retrospective study in Korea (KROG 16-12) | 김규보; 김경수 | Article |
2019 | Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines | 김승철; 문병인; 허정원; 임우성; 백남선; 정태동 | Article |